Paliperidone [144598-75-4]
P0144
Estimated Purity≥97%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NamePaliperidone [144598-75-4]
- Delivery Days Customer7
- CertificationResearch Use Only
- Estimated Purity≥97%
- FormatDMSO: >5 mg/mL
- Scientific DescriptionD2 and 5-HT2A antagonist.; 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, 9-OH-risperidone
- Storage InstructionAmbient
- UNSPSC12352200
References
- Kozielska M, Johnson M, Pilla Reddy V, et al. Pharmacokinetic-pharmacodynamic modeling of the D2 and 5-HT (2A) receptor occupancy of risperidone and paliperidone in rats. Pharm Res. 2012 Jul;29(7):1932-48. PMID: 22437487. Gilday E, Nasrallah HA. Clinical pharmacology of paliperidone palmitate a parenteral long-acting formulation for the treatment of schizophrenia. Rev Recent Clin Trials. 2012 Feb;7(1):2-9. PMID: 22023179. De Clerck F, Somers Y, Mannaert E, et al. In vitro effects of risperidone and 9-hydroxy-risperidone on human platelet function, plasma coagulation, and fibrinolysis. Clin Ther. 2004 Aug;26(8):1261-73. PMID: 15476907.